How to transfer my Wegovy prescription to Illinois

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight management, you might be wondering: Can I actually get these prescriptions through telehealth? The short answer is yes—and for many people, it’s become the most convenient and accessible path to evidence-based obesity treatment.

But as with any healthcare decision, the details matter. Federal rules, state regulations, provider qualifications, and patient eligibility all play a role in whether telehealth weight loss treatment is right for you. This guide breaks down everything you need to know in 2025.

The Federal Picture: Telehealth Prescribing is Fully Legal for Weight Loss Medications

Here’s the most important thing to understand: GLP-1 weight loss medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. That means they’re not subject to the Drug Enforcement Administration’s (DEA) Ryan Haight Act, which historically required an in-person visit before prescribing controlled medications via telehealth.

During the COVID-19 pandemic, the DEA temporarily waived even those controlled substance restrictions to expand healthcare access. As of December 2025, those temporary flexibilities remain in effect through the end of the year, with expectations for further extension into 2026. But for non-controlled medications—including all currently available GLP-1 agonists—there has never been a federal barrier to telehealth prescribing.

What this means for you: A licensed healthcare provider can legally evaluate you via video consultation and electronically send a prescription for weight loss medication to your pharmacy, as long as they establish an appropriate patient-provider relationship and you meet clinical criteria.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State Rules: Where You Live Still Matters

While federal law permits telehealth prescribing of these medications, individual states set additional requirements for telemedicine practice. Some states have embraced virtual care with minimal restrictions, while others require certain safeguards before prescribing weight management drugs remotely.

States Requiring an Initial In-Person Exam

Several states mandate that patients have at least one in-person physical examination before or shortly after starting telehealth treatment for weight loss:

• Arkansas: Requires an initial in-person visit to establish the patient-provider relationship
• Delaware: First exam must be conducted in person
• Georgia: Initial physical exam required before telehealth prescribing
• Mississippi: In-person evaluation needed at start of weight management therapy
• New Jersey: Comprehensive in-person exam including labs and risk assessment required
• North Dakota: Hands-on initial evaluation expected
• South Carolina: Must examine patient in person first
• Texas: Generally expects initial in-person exam as standard of care
• Virginia: Requires initial physical exam, laboratory work, and personalized diet/exercise plan

If you live in one of these states, your telehealth provider may coordinate with a local clinic for your initial visit, or they may require you to see a local provider before beginning virtual treatment.

States with Additional Prescribing Requirements

Some states don’t necessarily require in-person exams but impose other conditions:

Florida requires:

• BMI of 30 or higher (or 27+ with comorbidities)
• Follow-up visits at least every 3 months during treatment

Connecticut mandates:

• Behavioral counseling component
• Documented diet and exercise plan alongside medication

Virginia requires:

• 30-day follow-up visit after starting therapy
• Comprehensive treatment plan addressing lifestyle factors

States with Minimal Telehealth Restrictions

Many states have embraced telehealth for weight management with few specific barriers beyond standard medical practice requirements:

• California: Telehealth exam is legally sufficient; no in-person mandate
• Illinois: No special restrictions for weight-loss prescribing
• New York: Fully permits telehealth evaluation for obesity treatment
• Pennsylvania: No in-person requirement for GLP-1 prescriptions
• Washington: Pioneer telehealth state with broad virtual care permissions

Who Can Prescribe These Medications?

Physicians (MDs and DOs)

In all 50 states, licensed physicians can prescribe weight loss medications via telehealth, provided they’re licensed in the state where you’re physically located during the consultation.

Nurse Practitioners (NPs) and Physician Assistants (PAs)

The ability of NPs and PAs to prescribe these medications varies significantly by state:

Independent Practice States (NPs can prescribe without physician oversight):

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years)
• New York (after 3,600 clinical hours)
• Utah (full practice as of 2023)
• Virginia (after 2 years)
• Washington (full authority)

Collaborative Practice States (require physician agreement):

• Arkansas (APRN must have MD collaboration)
• Florida (some autonomy in primary care only)
• Georgia (can now prescribe Schedule II with physician delegation as of 2024)
• Illinois (written MD agreement required)
• Mississippi (collaboration required; FPA legislation pending)
• Pennsylvania (collaboration agreement needed)
• South Carolina (MD supervision with written protocol)
• Texas (physician delegation required; very restrictive)

At Klarity Health, our providers include both physicians and advanced practice providers who are fully licensed and credentialed in your state, ensuring your care meets all local requirements.

Are You Eligible? Understanding Clinical Criteria

Reputable telehealth providers screen patients carefully. These medications aren’t for everyone—they’re FDA-approved for adults who meet specific medical criteria.

Standard Eligibility Requirements

Most providers look for:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with weight-related health conditions like type 2 diabetes, high blood pressure, or high cholesterol
• Age 18 or older
• Commitment to lifestyle changes (diet and exercise)
• History of attempting weight loss through lifestyle modification

Medical Screening

During your telehealth consultation, expect your provider to review:

• Complete medical history
• Current medications and supplements
• Previous weight loss attempts
• Mental health history
• Family medical history (especially thyroid cancer)
• Current and recent lab work (if available)

Important Contraindications

You may not be eligible if you have:

• Personal or family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current pregnancy or plans to become pregnant
• History of pancreatitis
• Severe gastroparesis or gastrointestinal disease
• History of suicidal ideation or severe depression (requires careful evaluation)

What to Expect: The Telehealth Visit Process

Initial Consultation

A legitimate telehealth weight loss program will include:

1. Comprehensive Health Questionnaire: Detailed medical history, current health status, and weight history
2. Live Video Consultation: Real-time discussion with a licensed provider (not just a form or chatbot)
3. Vital Signs Review: Self-reported weight, height, blood pressure if available
4. Treatment Discussion: Realistic expectations, side effects, alternatives, and your responsibilities
5. Informed Consent: Clear explanation of risks and benefits

The consultation typically lasts 20-45 minutes for an initial visit.

After Your Consultation

If approved for treatment:

• Your prescription is sent electronically to your chosen pharmacy
• You’ll receive instructions for medication storage, injection technique, and dosing schedule
• Follow-up appointments will be scheduled (typically within 4 weeks initially)
• You’ll have access to provider messaging for questions or concerns

Ongoing Monitoring

Responsible telehealth programs include:

• Regular follow-up visits (monthly initially, then every 2-3 months)
• Weight tracking and progress reviews
• Side effect monitoring and dose adjustments
• Periodic lab work recommendations (metabolic panel, A1C if diabetic)
• Continuous lifestyle coaching and support

Klarity Health’s approach combines the convenience of telehealth with the rigor of in-person care: our providers conduct thorough evaluations, provide personalized treatment plans, and maintain regular contact throughout your weight loss journey—all at transparent pricing whether you’re using insurance or paying out of pocket.

Understanding the Medications

Wegovy (Semaglutide 2.4mg)

• FDA Status: Approved specifically for chronic weight management
• Schedule: Not a controlled substance
• How Supplied: Pre-filled injection pens, weekly dosing
• Typical Protocol: Start low, gradually increase dose over 16-20 weeks
• Key Points: This is the obesity-specific formulation of semaglutide. Prescriptions are typically written for 4-week supplies initially, then may extend to 90 days once stable.

Ozempic (Semaglutide 0.5-1mg)

• FDA Status: Approved for type 2 diabetes (used off-label for weight loss)
• Schedule: Not controlled
• How Supplied: Weekly injection pens
• Key Points: Same active ingredient as Wegovy but lower doses. When prescribed for weight loss, it’s considered off-label use—legitimate providers will document medical necessity and obtain informed consent for off-label prescribing.

Mounjaro (Tirzepatide) / Zepbound

• FDA Status: Mounjaro approved for diabetes; Zepbound approved for weight management
• Schedule: Not controlled
• How Supplied: Weekly injection pens in dose-escalation packs
• Key Points: Newer dual-action medication (GLP-1 and GIP agonist). Shows promising results for weight loss. As with Ozempic, off-label documentation needed if prescribing Mounjaro specifically for weight loss.

Important: The Compounding Issue

In 2025, the FDA ended the emergency allowance for compounding semaglutide, effectively banning most retail compounded versions. This decision came after determining that brand-name supply had stabilized. Be cautious of any telehealth service offering ‘compounded’ semaglutide—as of May 2025, these products are generally not FDA-approved and may not be legal to prescribe or dispense in most situations.

Stick with FDA-approved brand-name medications dispensed through licensed U.S. pharmacies.

Red Flags: How to Spot Questionable Telehealth Services

The popularity of weight loss medications has unfortunately attracted some less-than-reputable operators. Watch out for these warning signs:

🚩 Guaranteed prescriptions: Any service promising a prescription without a thorough medical evaluation

🚩 No live provider interaction: Platforms that rely solely on questionnaires without video consultations

🚩 Compounded or imported medications: Offers of cheaper ‘generic’ versions, overseas products, or compounded semaglutide

🚩 Lack of follow-up: No scheduled monitoring visits or side effect check-ins

🚩 Unclear provider credentials: Can’t verify who your prescriber is or what state they’re licensed in

🚩 Pressure tactics: High-pressure sales language, limited-time offers, or downplaying risks

🚩 No address or clinic affiliation: Virtual-only operations with no physical location or professional affiliations

What Legitimate Telehealth Looks Like

Reputable services should:

• Clearly display provider credentials and state licenses
• Require comprehensive medical screening
• Conduct live video consultations
• Discuss risks, benefits, and alternatives openly
• Schedule regular follow-up appointments
• Only prescribe FDA-approved medications through licensed U.S. pharmacies
• Accept questions and provide ongoing clinical support
• Have transparent pricing (whether cash or insurance-based)

Cost Considerations: Insurance vs. Cash Pay

Insurance Coverage

Coverage for weight loss medications varies widely:

• Some commercial insurance plans cover FDA-approved obesity medications
• Medicare traditionally didn’t cover weight loss drugs, though recent legislative changes may expand access
• Medicaid coverage varies by state
• Prior authorization is often required
• Copays can range from $25 to $100+ per month depending on your plan

Cash Pay Options

Many patients choose to pay out of pocket because:

• Insurance doesn’t cover their medication
• Copays are prohibitively expensive
• They prefer privacy (insurance claims create records)
• They want faster access without prior authorization delays

Cash prices for brand-name medications typically range from $900-$1,400 per month without insurance, though some telehealth platforms and pharmacy discount programs can reduce costs.

Klarity Health accepts both insurance and cash pay, with transparent upfront pricing so you know exactly what to expect. Our team can help you navigate insurance coverage or find the most affordable self-pay options.

Your Rights and Responsibilities as a Patient

You Have the Right To:

• Ask questions about your provider’s qualifications and experience
• Understand all costs before starting treatment
• Access your medical records from telehealth visits
• Receive the same standard of care as in-person visits
• Request a second opinion
• Stop treatment at any time
• Report concerns to state medical boards

Your Responsibilities Include:

• Providing accurate medical history information
• Attending scheduled follow-up appointments
• Reporting side effects or concerns promptly
• Following dosing instructions carefully
• Committing to lifestyle changes alongside medication
• Not sharing or selling your medication
• Using the medication only as prescribed

Looking Ahead: The Future of Telehealth Weight Management

The regulatory landscape continues to evolve in favor of expanded telehealth access:

Federal Developments:

• DEA’s temporary telehealth flexibilities extended through December 2025, with expectations for further extensions
• Bipartisan congressional support for making telehealth prescribing permanent (TREATS Act pending)
• Medicare coverage expansions under consideration

State Trends:

• Growing number of states granting full practice authority to NPs (34 states plus DC as of 2025)
• Interstate licensure compacts making multi-state practice easier
• General movement toward fewer telehealth restrictions

Medical Advances:

• New obesity medications in development
• Improved understanding of long-term GLP-1 therapy
• Integration of digital health tools with medication management

The trajectory is clear: telehealth for weight management is here to stay, with regulations continuing to modernize and expand access while maintaining appropriate safety standards.

Taking the Next Step

If you’re considering telehealth for weight loss medication:

1. Verify you meet eligibility criteria: Check your BMI and review contraindications
2. Research your state’s requirements: Understand whether an in-person visit is needed
3. Choose a reputable provider: Look for licensed, credentialed healthcare professionals with transparent practices
4. Gather your medical information: Recent weight history, current medications, relevant lab work
5. Schedule a consultation: Be prepared to discuss your health history honestly and ask questions
6. Commit to the full program: Medication works best alongside lifestyle changes and regular monitoring

Ready to explore your options? Klarity Health offers comprehensive telehealth weight management with licensed providers across multiple states, flexible scheduling including same-day appointments, transparent pricing with both insurance and cash-pay options, and ongoing support throughout your weight loss journey. Our providers are experienced in obesity medicine and committed to helping you achieve sustainable, healthy weight loss.

Frequently Asked Questions

Do I need to see a doctor in person before getting a weight loss prescription online?

It depends on your state. About half of U.S. states allow you to start treatment entirely via telehealth with no in-person requirement. The other states require an initial physical exam in person before or shortly after beginning online care. Check the state-specific table in this article for your location.

Are these medications controlled substances that are hard to get via telehealth?

No. Wegovy, Ozempic, and Mounjaro are not classified as controlled substances. They can be prescribed via telehealth under federal law without the restrictions that apply to medications like Adderall or other controlled drugs.

Can a nurse practitioner prescribe weight loss medication through telehealth?

Yes, in most states. Nurse practitioners can prescribe these medications, though some states require them to work under a physician collaboration agreement. In states with full practice authority (like California, New York, and Washington), NPs can prescribe independently.

How long does a telehealth visit for weight loss medication take?

Initial consultations typically last 20-45 minutes. Your provider will review your medical history, discuss treatment options, explain side effects, and answer your questions. Follow-up visits are usually shorter, around 15-20 minutes.

Will my insurance cover telehealth visits for weight loss medication?

Many insurance plans now cover telehealth visits at the same rate as in-person visits. However, coverage for the medications themselves varies widely. It’s best to check with your insurance provider about both visit coverage and prescription coverage before starting.

What if I move to a different state while on treatment?

You’ll need to establish care with a provider licensed in your new state. Many telehealth platforms, including Klarity Health, have providers in multiple states and can facilitate transfers, but you may need a new consultation to comply with your new state’s regulations.

Are online weight loss medications safe?

When prescribed by licensed healthcare providers through legitimate telehealth services, these FDA-approved medications are safe for appropriate candidates. The key is working with reputable providers who conduct thorough evaluations, monitor your progress, and only prescribe to patients who meet clinical criteria.

How quickly can I start medication after my telehealth visit?

If approved, your prescription is typically sent to your pharmacy electronically within hours of your visit. How quickly you receive the medication depends on pharmacy inventory—brand-name GLP-1s can sometimes have supply delays, though availability has improved significantly in 2025.

Research Currency Statement

Verified as of: December 17, 2025

DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.

States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of December 2025)

Sources: 15 of 18 sources are from 2024–2025; older sources used only for baseline context.

⚠️ Note: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025) – an additional extension or new rule is expected. State laws continue to evolve; monitor for any changes in 2026. FDA oversight on compounded GLP-1 medications tightened in 2025 – ensure compliance with current FDA guidance.

References

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 (Nov 15, 2024) – U.S. Drug Enforcement Administration. www.dea.gov

2. COVID-era telehealth prescribing extended (Nov 18, 2024) – Axios. www.axios.com

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 (Nov 18, 2024) – McDermott Will & Emery. www.mwe.com

4. The Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs (Mar 27, 2024) – Goodwin Procter LLP. www.goodwinlaw.com

5. Know Your State’s Laws Around Semaglutide (Apr 11, 2025) – Nextech. www.nextech.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid